Ranked by engagement
Top topics — all time page 31
Ranked by replies, likes and views over all time, with a bonus for topics that reached a marked solution. Engagement is a proxy for usefulness and a poor one; the documentation commons is the better index of what is settled.
1,535 topics · page 31 of 40
| Topic | Participants | Replies | Views | Activity |
|---|---|---|---|---|
|
Personal or family history of medullary thyroid carcinoma
Personal or family history of medullary thyroid carcinoma Writing it up because I had to work it out twice and would rather nobody else did. Asking about a contraindication as written rather than as…
|
+31 | 37 | 709 | 26d |
|
What published stability data actually covers, and what it does not — what changed since
What published stability data actually covers, and what it does not — what changed since — that is the question, and I have not found it answered plainly anywhere I have looked. What changes if the standard…
|
3 | 43k | 6mo | |
|
[2026 update] Conference abstracts as evidence: the weakest common citation
Conference abstracts as evidence: the weakest common citation — setting out what I have, and where I think it stops being reliable. Reading an unrefereed manuscript properly, and asking whether I am doing it…
|
2 | 48k | 7mo | |
|
[2026 update] Hello from a laboratory that does not do peptides
Hello from a laboratory that does not do peptides Writing it up because I had to work it out twice and would rather nobody else did. Saying hello, and stating my interest so that it is on the record rather…
|
2 | 49k | 4mo | |
|
A newcomer's list of things that confused me, and the fixes
A newcomer's list of things that confused me, and the fixes — setting out what I have, and where I think it stops being reliable. Question in the title. Context below, and I have tried to include the things…
|
+9 | 13 | 34k | 12mo |
|
Coming back to: Reading a meta-analysis you disagree with, fairly
Reading a meta-analysis you disagree with, fairly Writing it up because I had to work it out twice and would rather nobody else did. Reading a meta-analysis — I have the observation and I do not trust my…
|
+30 | 34 | 9.3k | 17mo |
|
AOD-9604 and the fragment hypothesis, revisited — does this still hold?
The question in the title: AOD-9604 and the fragment hypothesis, revisited — does this still hold? I will give what I have already checked below so nobody repeats it. What changes if the standard account of…
|
+7 | 11 | 31k | 19h |
|
Insurance and replacement policies, compared — the long version
Insurance and replacement policies, compared — the long version — setting out what I have, and where I think it stops being reliable. A narrow question about Insurance and replacement policies, deliberately…
|
+29 | 33 | 4.9k | 9mo |
|
Coming back to: Injection-site reactions: describing them precisely enough to be useful
On the subject in the title: Injection-site reactions: describing them precisely enough to be useful Working notes rather than a conclusion. Reading back through what has been written here about…
|
+21 | 25 | 22k | 8mo |
|
Peer-to-peer review: what actually happens on the call — one year on
Peer-to-peer review: what actually happens on the call — one year on — setting out what I have, and where I think it stops being reliable. The question about Peer-to-peer review that I actually want answered…
|
+2 | 6 | 41k | 5mo |
|
About the Contraindications category
Absolute and relative contraindications, and the conditions that change the calculus. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit is recorded with its…
|
+6 | 10 | 35k | 14mo |
|
Random versus fixed effects: choosing rather than defaulting
Random versus fixed effects: choosing rather than defaulting — setting out what I have, and where I think it stops being reliable. Random versus fixed effects, and specifically the version of it that the…
|
+16 | 20 | 22k | 13mo |
|
Why side effects reset at each escalation and that is not a failure — the long version
The question in the title: Why side effects reset at each escalation and that is not a failure — the long version I will give what I have already checked below so nobody repeats it. A narrow question about…
|
2 | 46k | 17mo | |
|
An ABAB design with a data table and honest limitations
An ABAB design with a data table and honest limitations Writing it up because I had to work it out twice and would rather nobody else did. An honest uncertainty about ABAB design rather than a disguised…
|
2 | 45k | 5mo | |
|
Bleeding at the injection site: normal, and what to do about it — does this still hold?
Bleeding at the injection site: normal, and what to do about it — does this still hold? — that is the question, and I have not found it answered plainly anywhere I have looked. Something changed and I would…
|
+20 | 24 | 16k | 15mo |
|
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one year on
Asking directly, because I could not find a straight answer: Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one — one year on A follow-up question about oral GLP-1 agonist that I…
|
+16 | 20 | 18k | 2mo |
|
About the Receptor biology category
GLP-1, GIP, glucagon and amylin receptor signalling, bias, desensitisation and central versus peripheral action. This post is a community wiki: any member at trust level 3 or above can edit it, and every edit…
|
+6 | 10 | 34k | 20d |
|
How this community labels and discusses unrefereed work — the long version
Asking directly, because I could not find a straight answer: How this community labels and discusses unrefereed work — the long version Reading an unrefereed manuscript properly, and asking whether I am doing…
|
+18 | 23 | 21k | 2mo |
|
Reading an MS report that only gives you a single number — the long version
Reading an MS report that only gives you a single number — the long version — setting out what I have, and where I think it stops being reliable. I would like to understand what this number means before I…
|
2 | 47k | 18mo | |
|
Confounding by indication, explained with a concrete example
On the subject in the title: Confounding by indication, explained with a concrete example Working notes rather than a conclusion. Comparing SURMOUNT-1 ( N Engl J Med , 2022) with SURPASS-2 ( N Engl J Med ,…
|
+21 | 25 | 21k | 11mo |
|
I have no scientific background — can I still follow the analytics categories?
The question in the title: I have no scientific background — can I still follow the analytics categories? I will give what I have already checked below so nobody repeats it. I want to check my reasoning…
|
+29 | 40 | 1.4k | 12d |
|
Introducing myself: pharmacist, sceptic, reluctant participant
Introducing myself: pharmacist, sceptic, reluctant participant Writing it up because I had to work it out twice and would rather nobody else did. Introducing myself before I ask anything, since the welcome…
|
+13 | 17 | 23k | 2mo |
|
Insomnia at a dose step: reported experiences
On the subject in the title: Insomnia at a dose step: reported experiences Working notes rather than a conclusion. A sleep question with what I actually recorded rather than how I feel about it. Bedtime and…
|
+20 | 24 | 18k | 8mo |
|
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold?
Asking directly, because I could not find a straight answer: How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — does this still hold? A question about how a record should be read rather than…
|
+24 | 28 | 8k | 1mo |
|
Travelling with an injectable: documentation and practicalities
Posting this under the heading it deserves: Travelling with an injectable: documentation and practicalities Everything below is what sits behind that. Documenting a stated criterion rather than an outcome,…
|
+37 | 42 | 2.1k | 1d |
|
Excipient function in a licensed injectable
Excipient function in a licensed injectable Writing it up because I had to work it out twice and would rather nobody else did. I was wrong about excipient function in a thread last spring and I would like to…
|
+3 | 7 | 36k | 14mo |
|
Validating a calculator against hand arithmetic
Validating a calculator against hand arithmetic Writing it up because I had to work it out twice and would rather nobody else did. Validating a calculator against hand: setting out the arithmetic in full,…
|
+17 | 21 | 12k | 3mo |
|
Needle changes between doses on a reusable pen — does this still hold?
Needle changes between doses on a reusable pen — does this still hold? I have a specific reason for asking rather than idle curiosity, and the context is below. Posting a small dataset on Needle changes…
|
+1 | 5 | 38k | 13mo |
|
Follow-up: UK access routes, dated and sourced
On the subject in the title: UK access routes, dated and sourced Working notes rather than a conclusion. Regional question, dated March 2026, because everything in this category expires. The position differs…
|
+10 | 14 | 27k | 2d |
|
Review cadence: how often is a page actually re-checked?
Asking directly, because I could not find a straight answer: Review cadence: how often is a page actually re-checked? I would like to know what people here actually do about review cadence, as distinct from…
|
+20 | 24 | 20k | 15mo |